Blog
General

Making a CRO Shortlist: Finding the Right Partner for Your Study

Choosing the right Contract Research Organization (CRO) is critical to the success of your clinical trial. A structured approach to researching and evaluating CROs can help you identify the best fit for your study’s unique needs.

Evaluate Existing Relationships vs. Fresh Searches

Your starting point should involve assessing your existing relationships. Leveraging pre-existing relationships can save time and provide confidence in your choice, as you’ll be familiar with their capabilities and working style.

However, relying solely on past partnerships may limit your options. If you’re entering a new therapeutic area or need specialized services that your previous CRO hasn’t provided, conducting fresh research is essential. Begin with industry forums, professional networks, or even a quick Google search to begin identifying CROs that align with your requirements. Sites like Fierce Biotech and BioPharma Dive often showcase CROs with expertise in various therapeutic areas.

Assess Internal Capacities and Identify Gaps

Take a close look at your internal team’s expertise and resources. Does your team have experience in actually managing the clinical trials? If so, do they have exposure in managing the unique elements required of your current study? Whether it’s full-service trial management or support for specific clinical operations, having clarity on your needs will streamline the selection process.

Look for Therapeutic Area Expertise

One of the most critical factors in choosing a CRO is their experience in your study’s therapeutic area. A CRO with a proven track record in your specific field will be familiar with:

  • Patient populations and recruitment challenges
  • Regulatory requirements and regional considerations
  • Trial design nuances that align with your therapeutic focus

For example, if you’re conducting an oncology trial, a CRO with oncology experience will already understand the complexities of managing such studies, including specialized protocols, longer trial durations, and sensitive patient populations. Don’t hesitate to ask for case studies or references to verify their expertise.

Evaluate Technology Integration

Modern clinical trials rely heavily on technology for efficiency and data accuracy. It’s crucial to assess how well a CRO integrates technology into their operations. Key platforms to inquire about include:

  • Electronic Patient-Reported Outcomes (ePRO): These systems allow patients to report data for subjective experiences (i.e. quality of life, symptoms, adherence) remotely, enhancing compliance and reducing site visits.
  • Electronic Data Capture (EDC): An effective EDC system ensures clean, real-time data collection and easy accessibility for analysis.
  • Clinical Trial Management System (CTMS): A robust CTMS streamlines trial oversight, from tracking milestones to managing budgets.

Other tools you may find useful include visit scheduling, IRT/randomization, and pre-screening. Lindus Health integrates all of these and more within their proprietary eClinical software, Citrus™.

Consider Site Services and Virtual Capabilities

Site management is another crucial aspect to consider. Traditional CROs may excel in managing physical sites, but with the rise of decentralized clinical trials (DCTs), you may need a partner that can accommodate virtual site capabilities. Ask potential CROs:

If your study involves remote technologies like wearable devices or telemedicine, a CRO with experience in DCTs will be better equipped to handle these elements. This capability not only broadens your participant pool but also improves trial efficiency and participant retention.

Conduct In-Depth Due Diligence

Once you’ve narrowed down your list, it’s time to dig deeper. Schedule calls or meetings with the shortlisted CROs to evaluate their capabilities further. Topics to cover include:

  • Regulatory Expertise: Confirm their knowledge of regulations in your target regions, especially if your trial spans multiple countries.
  • Project Management: Assess their team’s experience and approach to communication, timelines, and problem-solving.
  • Quality Assurance: Ensure they have robust processes to maintain data integrity and compliance.
  • Cultural Fit: Evaluate whether their working style aligns with your team’s values and expectations.

Additionally, request proposals and quotes to compare costs and services side by side. Remember, the cheapest option isn’t always the best, so it’s important to prioritize quality and expertise over cost savings.

Conclusion

Selecting the right CRO is a crucial decision that directly impacts the success of your clinical trial. By taking a structured approach—assessing existing relationships, evaluating internal capabilities, researching therapeutic expertise, and considering technology integration—you can narrow down your options effectively.

Once you’ve shortlisted potential partners, conducting in-depth due diligence will ensure you find a CRO that not only meets regulatory and quality standards but also integrates seamlessly with your team. By prioritizing expertise, communication, and a shared commitment to trial success, you’ll set your study up for efficiency, compliance, and, ultimately, better outcomes for patients.

This is some text inside of a div block.
This is some text inside of a div block.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Continue reading

More from Lindus

Lindus BG Image
11 Mar 2026
Blog

Achieving FDA-Grade Data Quality in Large-Scale Liquid Biopsy Screening Trials

"The data pipeline, from medical record retrieval to structured EDC output, has to be designed for regulatory scrutiny from the start. Retrofitting data quality into an operational model that wasn't built for it creates avoidable risk at exactly the wrong stage of a program."

Lindus BG Image
26 Feb 2026
Blog

Maintaining Complete Long-Term Follow-Up Data in Large-Scale Oncology Screening Trials

Every cancer case in a large screening trial must be fully documented, with complete diagnostic, staging, treatment, and outcome data. Losing even a small number of cases to incomplete follow-up can undermine the statistical power the entire study was designed to achieve. The operational model has to be built around preventing that from the start.

Lindus BG Image
17 Feb 2026
Blog

Scaling Liquid Biopsy Trial Enrollment Through Decentralized and Hybrid Models

"Clinical trials for diagnostics are increasingly time-consuming and expensive, given the large volumes of patients required. Identification and proper enrollment at accredited sites alongside novel methods of reaching patients remotely are promising developments for speeding and focusing efforts."

Lindus BG Image
20 Jan 2026
Blog

Why the FDA's Bayesian Draft Guidance Matters for Clinical Development

Last week, the FDA published draft guidance designed to facilitate the use of Bayesian methodologies in clinical trials of drugs and biologics. It is a welcome step toward faster, more practical clinical development that puts patients first, especially those for whom a clinical trial is often their best hope.